Two-photon photodynamic therapy and its potential application to age related macular degeneration

Two-photon photodynamic therapy and its potential application to age related macular degeneration

Photodynamic therapy (PDT) using verteporfin is widely used for treatment of age related macular degeneration (AMD). Due to non-perfect selectivity of the drug accumulation in the neovasculature some collateral damage to healthy tissue arises during the treatment. Damage to healthy structures in the...

Bibliografske podrobnosti
Main Authors:	Karotki, A, Khurana, M, Bisland, S, Moriyama, E, Simpson, E, Campbell, M, Collins, H, Anderson, H, Cramb, D, Wilson, B
Format:	Journal article
Jezik:	English
Izdano:	2007

Podobne knjige/članki

Quantitative in vitro demonstration of two-photon photodynamic therapy using photofrin and visudyne.
od: Khurana, M, et al.
Izdano: (2007)

In vitro studies of the efficiency of two-photon activation of photodynamic therapy agents
od: Khurana, M, et al.
Izdano: (2006)

MEDI 272-Two-photon excited photodynamic therapy using water-soluble porphyrin dimers
od: Balaz, M, et al.
Izdano: (2007)

NORMAL FLUENCE PHOTODYNAMIC THERAPY ASSOCIATED WITH LAMELLAR MACULAR HOLES IN EXUDATIVE AGE RELATED MACULAR DEGENERATION
od: Alvaro Rodriguez, et al.
Izdano: (2014-09-01)

Multi-modality optical imaging of vascular responses to photodynamic therapy in mouse window chamber model
od: Khurana, M, et al.
Izdano: (2008)

Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone
od: Jos&eacute; M&ordf; Ruiz-Moreno, et al.
Izdano: (2008-03-01)

Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK
od: BC Reeves, et al.
Izdano: (2012-02-01)

Synthesis of hydrophilic conjugated porphyrin dimers for one-photon and two-photon photodynamic therapy at NIR wavelengths.
od: Balaz, M, et al.
Izdano: (2009)

Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular Degeneration
od: Shuting Xu, et al.
Izdano: (2023-11-01)

Changes in visual function and thickness of macula after photodynamic therapy for age-related macular degeneration
od: Kyoko Okada, et al.
Izdano: (2009-09-01)

Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
od: Mamdouh M Kabeel, et al.
Izdano: (2008-03-01)

One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration
od: Tomoko Nakamura, et al.
Izdano: (2012-01-01)

Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration
od: Azarmina Mohsen, et al.
Izdano: (2007-06-01)

Prognostic phenotypic and genotypic factors associated with photodynamic therapy response in patients with age-related macular degeneration
od: Tsuchihashi T, et al.
Izdano: (2014-12-01)

Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration
od: Tsuchihashi T, et al.
Izdano: (2013-03-01)

Combined photodynamic therapy and intravitreal ranibizumab as treatment for extrafoveal choroidal neovascularization associated with age-related macular degeneration
od: Jay Kumar Chhablani
Izdano: (2010-01-01)

Transient accumulation of subretinal fluid after half-fluence photodynamic therapy in neovascular age-related macular degeneration
od: Min Ho Kim, et al.
Izdano: (2021-02-01)

Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration
od: Pukhraj Rishi, et al.
Izdano: (2011-02-01)

Two-Photon Vision in Age-Related Macular Degeneration: A Translational Study
od: Grzegorz Łabuz, et al.
Izdano: (2022-03-01)

Verteporfin photodynamic therapy combined with intravitreal ranibizumab in neovascular age-related macular degeneration: 24-month follow-up
od: Rosalia Giustolisi, et al.
Izdano: (2014-09-01)

On the efficiency of treatment of wet age-related macular degeneration with Lucentis
od: E. M. Kasimov, et al.
Izdano: (2018-10-01)

Age-related macular degeneration
od: Querques G, et al.
Izdano: (2011-05-01)

Age-related macular degeneration
od: Wanjiku Mathenge
Izdano: (2014-12-01)

MEDI 118-Conjugated porphyrin dimers with large two-photon absorption cross section for photodynamic therapy
od: Balaz, M, et al.
Izdano: (2007)

Photodynamic therapy and intravitreal bevacizumab with versus without triamcinolone for neovascular age-related macular degeneration; a randomized clinical trial
od: Niloofar Piri, et al.
Izdano: (2014-01-01)

Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation
od: C. Meads, et al.
Izdano: (2003-01-01)

Treatment of large avascular retinal pigment epithelium detachments in age-related macular degeneration with aflibercept, photodynamic therapy, and triamcinolone acetonide
od: Tvenning AO, et al.
Izdano: (2019-02-01)

Age-related macular degeneration and the aging eye
od: Rita Ehrlich, et al.
Izdano: (2008-09-01)

Photon energy upconversion in porphyrins: one-photon hot-band absorption versus two-photon absorption
od: Drobizhev, M, et al.
Izdano: (2003)

Gene therapy for age-related macular degeneration
od: MacLaren, RE
Izdano: (2015)

Targeted Therapy on Age-Related Macular Degeneration
od: Vankodoth Sireesha, et al.
Izdano: (2024-12-01)

Pharmacoeconomic analysis of anti-VEGF therapy for age-related macular degeneration
od: A. E. Cheberda, et al.
Izdano: (2018-05-01)

Implantation of the First IMT Macular Lens in Age-Related Macular Degeneration (Literature Review)
od: M. M. Bikbov, et al.
Izdano: (2019-08-01)

Age-Related Macular Degeneration and Circadian Preference
od: Garces E, et al.
Izdano: (2025-03-01)

Characterizing Macular Neovascularization in Myopic Macular Degeneration and Age-Related Macular Degeneration Using Swept Source OCTA
od: Sayah DN, et al.
Izdano: (2023-12-01)

Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions
od: Otsuji T, et al.
Izdano: (2016-03-01)

Pharmacogenetics and Age-Related Macular Degeneration
od: Stephen G. Schwartz, et al.
Izdano: (2011-01-01)

Choriocapillaris in Age-Related Macular Degeneration
od: Giovanni Neri, et al.
Izdano: (2024-08-01)

Nanotechnology for Age-Related Macular Degeneration
od: Bo Yang, et al.
Izdano: (2021-11-01)

Age-Related Macular or Retinal Degeneration?
od: Michalina Gałuszka, et al.
Izdano: (2023-05-01)